124 related articles for article (PubMed ID: 26897936)
1. Clinicopathological Features of Second Primary Colorectal Cancer Incidentally Identified by 18F-FDG-PET.
Fujii T; Suto T; Kigure W; Morita H; Katoh T; Yajima R; Tsutsumi S; Asao T; Kuwano H
Hepatogastroenterology; 2015 May; 62(139):599-601. PubMed ID: 26897936
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analysis and risk factors of advanced colorectal neoplasms incidentally detected by 18F-FDG PET-CT.
Chung SM; Kim KO; Cho IH; Kim TN
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):407-413. PubMed ID: 27926665
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
Furukawa H; Ikuma H; Seki A; Yokoe K; Yuen S; Aramaki T; Yamagushi S
Gut; 2006 Jul; 55(7):1007-11. PubMed ID: 16361308
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of second primary cancer using integrated [18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging.
Choi JY; Lee KS; Kwon OJ; Shim YM; Baek CH; Park K; Lee KH; Kim BT
J Clin Oncol; 2005 Oct; 23(30):7654-9. PubMed ID: 16234527
[TBL] [Abstract][Full Text] [Related]
7. Preoperative 18F-FDG PET/CT predicts disease-free survival in patients with primary invasive ductal breast cancer.
Jo JE; Kim JY; Lee SH; Kim S; Kang T
Acta Radiol; 2015 Dec; 56(12):1463-70. PubMed ID: 25406431
[TBL] [Abstract][Full Text] [Related]
8. Impact of routine preoperative
Mogollón-González M; Conde-Muiño R; Rodríguez-Fernández A; Navarro-Pelayo M; Domínguez-Bastante M; Palma P
J Surg Oncol; 2023 Aug; 128(2):295-303. PubMed ID: 37092877
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
[TBL] [Abstract][Full Text] [Related]
10. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of 2-[
Sekiguchi M; Kakugawa Y; Terauchi T; Matsumoto M; Saito H; Muramatsu Y; Saito Y; Matsuda T
J Gastroenterol; 2016 Dec; 51(12):1122-1132. PubMed ID: 27021493
[TBL] [Abstract][Full Text] [Related]
12. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
14. Resected colorectal cancer among Medicare beneficiaries:adoption of FDG PET.
Zafar HM; Mahmoud NN; Mitra N; Wirtalla C; Armstrong K; Groeneveld PW
Radiology; 2010 Feb; 254(2):501-8. PubMed ID: 20093522
[TBL] [Abstract][Full Text] [Related]
15. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
[TBL] [Abstract][Full Text] [Related]
16. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
[TBL] [Abstract][Full Text] [Related]
17. Predictors of initial 18F-fluorodeoxyglucose-positron emission tomography indication among patients with colorectal cancer.
Zafar HM; Kramer S; Bonaccorsi D; Langlotz CP; Armstrong K
Nucl Med Commun; 2012 Jul; 33(7):739-46. PubMed ID: 22531828
[TBL] [Abstract][Full Text] [Related]
18. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
19. The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancer.
Pelosi E; Deandreis D
Eur J Surg Oncol; 2007 Feb; 33(1):1-6. PubMed ID: 17126522
[TBL] [Abstract][Full Text] [Related]
20. Incidental detection of colorectal malignancies using FDG PET-CT.
Fleming M; Knox M; Kennedy MJ
Ir Med J; 2013 May; 106(5):151-3. PubMed ID: 23914580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
